Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: Metoprolol vs. Diltiazem - 03/02/21
, Ellen E. Robinson, PharmD a, b, c, d, Kathleen A. Lusk, PharmD a, b, d, Darrel W. Hughes, PharmD a, b, c, Luke A. Neff, PharmD a, b, c, d, Amanda L. Fowler, PharmD a, b, c, dAbstract |
Objective |
The objective of this study was to compare sustained rate control with intravenous (IV) diltiazem vs. IV metoprolol in acute treatment of atrial fibrillation (AF) with rapid ventricular rate (RVR) in the emergency department (ED).
Methods |
This retrospective chart review at a large, academic medical center identified patients with AF with RVR diagnosis who received IV diltiazem or IV metoprolol in the ED. The primary outcome was sustained rate control defined as heart rate (HR) < 100 beats per minute without need for rescue IV medication for 3 h following initial rate control attainment. Secondary outcomes included time to initial rate control, HR at initial control and 3 h, time to oral dose, admission rates, and safety outcomes.
Results |
Between January 1, 2016 and November 1, 2018, 51 patients met inclusion criteria (diltiazem n = 32, metoprolol n = 19). No difference in sustained rate control was found (diltiazem 87.5% vs. metoprolol 78.9%, p = 0.45). Time to rate control was significantly shorter with diltiazem compared to metoprolol (15 min vs. 30 min, respectively, p = 0.04). Neither hypotension nor bradycardia were significantly different between groups.
Conclusions |
Choice of rate control agent for acute management of AF with RVR did not significantly influence sustained rate control success. Safety outcomes did not differ between treatment groups.
Le texte complet de cet article est disponible en PDF.Keywords : Atrial fibrillation, Metoprolol, Diltiazem, Arrhythmia, Emergency department
Plan
| ☆ | All authors approved the final manuscript as submitted. |
Vol 40
P. 15-19 - février 2021 Retour au numéro
Article précédent
- Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality
- Elnaz Vafadar Moradi, Ali Teimouri, Ramin Rezaee, Negar Morovatdar, Mahdi Foroughian, Parvaneh Layegh, Behrang Rezvani Kakhki, Seyed Reza Ahmadi Koupaei, Vahideh Ghorani
- Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system
- Theodoros V. Giannouchos, Joseph Biskupiak, Michael J. Moss, Diana Brixner, Elena Andreyeva, Benjamin Ukert
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?